Delta Neutrophil Index and Neutrophil‐to‐Lymphocyte Ratio in the Differentiation of Thyroid Malignancy and Nodular Goiter
- 16 October 2020
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 45 (2) , 507-514
Abstract
Background: It was aimed to evaluate the relationship between delta neutrophil index (DNI) and neutrophil‐to‐lymphocyte ratio (NLR) in the preoperative differentiation of nodular goiter and thyroid malignancy.Methods: Patients over the age of 18 who underwent thyroid surgery between November 2014 and November 2019 were evaluated in this retrospective cohort study. Patients were divided into two groups according to their pathology results: malignant (Group M) and benign (Group B) thyroid disorders. White blood cell (WBC) count, neutrophil count, lymphocyte count, IG count and DNI were measured using an automated hematological analyzer from blood samples obtained at the preoperative period and postoperative 6th month of the follow‐up. Neutrophil‐to‐lymphocyte ratio (NLR) values were manually calculated. Numerical data are expressed as means ± standard deviations (minimum–maximum values) or medians (minimum–maximum values) according to the normal distribution. Categorical values are expressed as percentages (%).Results: A total of 243 patients (190 patients in Group B and 53 patients in Group M) who met the inclusion criteria were evaluated. The male/female ratio was 49/194. A statistically significant difference between Group M and Group B in terms of preoperative NLR, DNI and IG count was observed (p = 0.001, < 0.001 and < 0.001, respectively). No statistically significant difference was observed between the groups in terms of the control values performed in the postoperative period in terms of the NLR, DNI and IG count (p = 0.711, 0.333 and 0.714, respectively). A significant decrease was observed in the preoperative and postoperative DNIs, IG counts and NLRs in Group M (p = 0.009, < 0.001 and < 0.001, respectively). For the diagnosis of malignant thyroid diseases, the cut‐off value of DNIs was ≥0.35%, and DNI sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were 79.2%, 78.9%, 79.2% and 77.9%, respectively (area under the curve [AUC]: 0.847; confidence interval [CI]: 0.784–0.911). The cut‐off value of the IG count was ≥25/mm3, and its sensitivity, specificity, PPV and NPV were 83%, 72.1%, 83%, and 72.1%, respectively (AUC: 0.847; CI: 0.784–0.911).Conclusion: DNI and IG counts are cheap and easily accessible tests that can be automatically calculated from automated systems without additional cost in differentiation of thyroid malignancies from benign disorders in the preoperative period.Keywords
This publication has 28 references indexed in Scilit:
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- May the Neutrophil/Lymphocyte Ratio Be a Predictor in the Differentiation of Different Thyroid Disorders?Asian Pacific Journal of Cancer Prevention, 2015
- Delta Neutrophil Index as a Promising Prognostic Marker in Out of Hospital Cardiac ArrestPLOS ONE, 2015
- Association of the Preoperative Neutrophil-to-ymphocyte Count Ratio and Platelet-to-Lymphocyte Count Ratio with Clinicopathological Characteristics in Patients with Papillary Thyroid CancerEndocrinology and Metabolism, 2015
- Ultrasonographic thyroid findings suspicious for malignancyDiagnostic Cytopathology, 2013
- The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot studyThe American Journal of Surgery, 2013
- Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancerTumor Biology, 2011
- Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable CancerFuture Oncology, 2009
- Activated human neutrophils release hepatocyte growth factor/scatter factorEuropean Journal of Surgical Oncology, 2001
- Inflammation and cancer: back to Virchow?The Lancet, 2001